Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (259)	6/1/1998 4:15:00 PM
From: Jay Lowe	Read Replies (2) \| Respond to of 586

OK ... will edit together an issue list. Another of my holdings is transiting a hot spot, so my SI time is going there right now ... it'll be a couple of days. Another point about the FDA news is that the big investors have already largely priced approval into the stock ... they are assuming the approval. The real question becomes can CYPB get into the market ... can they get those docs out there to pick up their pads and write "Prosorba" or whatever. That's the key. We know it works. We can guess the FDA will pass it. Will Cypress be able to market it? To what extent will the docs pick up on it? That's the key. If they do, this is a $10 stock, if not, not.